Boston Scientific Corp (BSX)
Healthcare
Medical Devices
46.70 $
+1.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Boston Scientific Corp (BSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 5,442 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,527 | 3,725 | 3,856 | 4,120 | 4,209 | 4,561 | 4,663 | 5,061 | 5,065 | 5,286 | 5,203 | 5,442 | 20,996 | |
| 1,360 | 1,413 | 1,472 | 1,535 | 1,561 | 1,890 | 1,713 | 1,637 | 1,523 | 1,348 | 1,590 | 1,594 | 6,055 | |
| 2,167 | 2,312 | 2,384 | 2,585 | 2,648 | 2,671 | 2,950 | 3,424 | 3,542 | 3,937 | 3,613 | 3,848 | 14,940 | |
| 356 | 363 | 366 | 383 | 407 | 460 | 443 | 526 | 514 | 569 | 516 | 554 | 2,153 | |
| 1,242 | 1,379 | 1,364 | 1,446 | 1,562 | 1,612 | 1,597 | 1,716 | 1,741 | 1,834 | 1,781 | – | – | |
| 1,609 | 1,754 | 1,740 | 1,838 | 1,974 | 2,082 | 2,054 | 2,605 | 2,492 | 2,731 | 2,541 | 2,670 | 10,434 | |
| 558 | 558 | 644 | 747 | 674 | 589 | 896 | 819 | 1,050 | 1,206 | 1,072 | 1,178 | 4,506 | |
| 67 | 67 | 72 | 81 | 83 | 139 | 87 | 90 | 87 | 90 | 90 | 96 | 363 | |
| 609 | 505 | 608 | 420 | 668 | 585 | 805 | 941 | 939 | 700 | 1,162 | 1,060 | 3,861 | |
| 105 | 1.0 | 115 | 98 | 200 | 23 | 133 | 146 | 183 | 31 | -176 | 155 | 193 | |
| 504 | 504 | 494 | 324 | 469 | 566 | 674 | 793 | 755 | 668 | 1,337 | 907 | 3,667 | |
| 976 | 885 | 984 | 812 | 1,058 | 1,071 | 1,217 | 1,367 | 1,368 | 1,155 | 1,603 | 1,389 | 5,515 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.